Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)

The summary for the Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved contraceptive products for men and women.
Federal Grant Title: Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HD-19-004
Type of Funding: Grant
CFDA Numbers: 93.865
CFDA Descriptions: Information not provided
Current Application Deadline: April 16th, 2018
Original Application Deadline: April 16th, 2018
Posted Date: February 14th, 2018
Creation Date: February 14th, 2018
Archive Date: May 22nd, 2018
Total Program Funding: $1,500,000
Maximum Federal Grant Award: $225,000
Minimum Federal Grant Award:
Expected Number of Awards: 6
Cost Sharing or Matching: No
Last Updated: February 14th, 2018
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-004.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical T...
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01 - Clinical T...
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Re...
Identification and Management of Behavioral Symptoms and Mental Health Conditions in Indiv...
Safe and Effective Devices for Use In Neonatal, Perinatal and Pediatric Care Settings (R43...
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...
Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)
Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical...
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical T...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com